GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche February 13, 2017 Johnson & Johnson Selling LifeScan Unit for $2.1 Billion March 15, 2018 How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017
Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche February 13, 2017
How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017
